tirzepatide eli lily Lilly plans diabetes drug trial for kids as young as 6 years, Bloomberg reports Eli Lilly seeks FDA approval

Anvisas approval of CuraTeQs Hyderabad facility strengthens Aurobindos ability to supply biosimilars across Brazil and Latin America while advancing its wider biologics manufacturing strategy

Results from the TRIUMPH-1 Phase 3 trial show participants on 9mg losing an average of 23.7% of body weight, and those on 12mg losing 25% at 80 weeks overall with the subgroup of participants escalated to maximum tolerated dose achieving the full 28.3% Synedica Retatrutide weight loss result

Glutathione S-transferases (GST) are an important group of enzymes that catalyze the nucleophilic addition of GSH to electrophiles

This imbalance is actually intentional